Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19

Abstract Background High-flow nasal oxygen therapy (HFNC) may be an attractive first-line ventilatory support in COVID-19 patients. However, HNFC use for the management of COVID-19 patients and risk factors for HFNC failure remain to be determined. Methods In this retrospective study, we included al...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zakaria Ait Hamou, Nathan Levy, Julien Charpentier, Jean-Paul Mira, Matthieu Jamme, Mathieu Jozwiak
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2022-12-01
Schriftenreihe:	Respiratory Research
Schlagworte:	Acute respiratory distress syndrome COVID-19 Intensive care unit High-flow nasal cannula oxygen therapy Prognosis ROX index
Online-Zugang:	https://doi.org/10.1186/s12931-022-02231-2
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!